Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4,884 INR | -0.55% | +2.90% | -6.13% |
04-16 | Alkem Laboratories Limited Receives A Demand Order Levying A Penalty of INR 35,099 State Tax Officer, Ghatak | CI |
03-28 | Alkem Laboratories Forms Subsidiary for Medical Devices Business | MT |
Sales 2024 * | 129B 1.55B 2.11B | Sales 2025 * | 142B 1.7B 2.33B | Capitalization | 587B 7.04B 9.61B |
---|---|---|---|---|---|
Net income 2024 * | 18.67B 224M 306M | Net income 2025 * | 21.7B 260M 355M | EV / Sales 2024 * | 4.39 x |
Net cash position 2024 * | 20.12B 241M 329M | Net cash position 2025 * | 27.86B 334M 456M | EV / Sales 2025 * | 3.93 x |
P/E ratio 2024 * |
32.1
x | P/E ratio 2025 * |
27.2
x | Employees | 16,871 |
Yield 2024 * |
0.88% | Yield 2025 * |
0.99% | Free-Float | 36.2% |
Latest transcript on Alkem Laboratories Limited
1 day | -0.55% | ||
1 week | +2.90% | ||
Current month | -1.18% | ||
1 month | -2.51% | ||
3 months | -1.85% | ||
6 months | +32.28% | ||
Current year | -6.13% |
Managers | Title | Age | Since |
---|---|---|---|
Vikas Gupta
CEO | Chief Executive Officer | - | 23-09-21 |
Nitin Agrawal
DFI | Director of Finance/CFO | - | 01-31 |
Manish Narang
CMP | Compliance Officer | 54 | 06-10-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 60 | - | |
Chief Executive Officer | 84 | 73-08-07 | |
Sandeep Singh
BRD | Director/Board Member | 41 | 13-08-08 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.23% | 6 M€ | +6.07% | - | |
0.01% | 31 M€ | +3.50% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 4,884 | -0.55% | 140 520 |
24-04-26 | 4,910 | +0.88% | 160,192 |
24-04-25 | 4,868 | +3.11% | 150,059 |
24-04-24 | 4,721 | +0.35% | 55,269 |
24-04-23 | 4,704 | -0.87% | 145,622 |
Delayed Quote NSE India S.E., April 29, 2024 at 07:40 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-6.13% | 7.04B | |
+25.83% | 661B | |
+26.27% | 566B | |
-6.76% | 352B | |
+20.34% | 332B | |
+3.00% | 283B | |
+14.66% | 231B | |
+5.41% | 200B | |
-8.96% | 195B | |
-6.26% | 145B |
- Stock Market
- Equities
- ALKEM Stock